- UroToday Home
- Recent Abstracts
- Urologic Oncology
Renal Cancer
Phase II and biomarker study of the dual MET/VEGFR2 inhibitor foretinib in patients with papillary renal cell carcinoma - Abstract
March 28, 2013
Treatment experience of the metastatic renal cell carcinomas to the head and neck region in our department - Abstract
March 27, 2013
The role of metastasectomy in renal cell carcinoma in the era of targeted therapy - Abstract
March 26, 2013
Posterior reversible encephalopathy syndrome induced by pazopanib for renal cell carcinoma - Abstract
March 26, 2013
Metastatic gastric tumors arising from renal cell carcinoma: Clinical characteristics and outcomes of this uncommon disease - Abstract
March 25, 2013
Experience with sorafenib in the treatment of advanced renal cell carcinoma - Abstract
March 25, 2013
Renal cell cancer diagnosed at endoscopy - Abstract
March 25, 2013
Cystic renal neoplasms and renal neoplasms associated with cystic renal diseases in adults: Cross-sectional imaging findings - Abstract
March 22, 2013
Novel agents, combinations and sequences for the treatment of advanced renal cell carcinoma: When is the revolution coming? - Abstract
March 22, 2013
Chromophobe subtype renal cell carcinoma in childhood: a case report and overview of the literature - Abstract
March 21, 2013
Image-guided biopsy of small renal masses in the era of ablative therapies - Abstract
March 21, 2013
Presurgical downstaging of vena caval tumor thrombus in advanced clear cell renal cell carcinoma using temsirolimus - Abstract
March 21, 2013
Primary resistance to tyrosine kinase inhibitors in patients with advanced renal cell carcinoma: State-of-the-science - Abstract
March 20, 2013
Phase II trial of everolimus for the treatment of nonclear-cell renal cell carcinoma - Abstract
March 20, 2013